GIM
Greylin Investment Management Portfolio holdings
AUM
$598M
This Quarter Return
-1.1%
1 Year Return
+18.59%
3 Year Return
+52.1%
5 Year Return
+133.55%
10 Year Return
+215.01%
AUM
$461M
AUM Growth
+$461M
(-0.25%)
Cap. Flow
+$3.76M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
72.96%
Holding
83
New
7
Increased
23
Reduced
41
Closed
4
Top Buys
| 1 |
United Therapeutics
UTHR
|
$4.35M |
| 2 |
Qualcomm
QCOM
|
$2.55M |
| 3 |
Gilead Sciences
GILD
|
$2.29M |
| 4 |
Exxon Mobil
XOM
|
$2.22M |
| 5 |
IBM
IBM
|
$1.84M |
Top Sells
| 1 |
Tapestry
TPR
|
$6M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$3.38M |
| 3 |
GSK
GSK
|
$1.49M |
| 4 |
WPP
WPP
|
$1.22M |
| 5 |
Wells Fargo
WFC
|
$1.05M |
Sector Composition
| 1 | Financials | 37.1% |
| 2 | Energy | 19.78% |
| 3 | Healthcare | 12.38% |
| 4 | Technology | 10.36% |
| 5 | Consumer Discretionary | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.09T
| $142M | 30.91% | 714,140 -16,927 | -2% | -$3.38M |
|
|
USG
2
DELISTED
Usg
USG
| $33.6M | 7.3% | 831,929 -23,801 | -3% | -$962K |
|
|
3
Exxon Mobil
XOM
$487B
| $31.8M | 6.91% | 426,855 +29,820 | +8% | +$2.22M |
|
|
4
IBM
IBM
$227B
| $29M | 6.29% | 188,981 +11,967 | +7% | +$1.84M |
|
|
5
Tapestry
TPR
$21.2B
| $27.3M | 5.92% | 518,605 -114,100 | -18% | -$6M |
|
6
BP
BP
$90.8B
| $18.8M | 4.08% | 463,850 -1,380 | -0.3% | -$55.9K |
|
7
Johnson & Johnson
JNJ
$427B
| $16.1M | 3.49% | 125,482 -380 | -0.3% | -$48.7K |
|
8
Merck
MRK
$210B
| $13.8M | 2.99% | 253,365 -1,020 | -0.4% | -$55.6K |
|
9
Bank of America
BAC
$376B
| $12.1M | 2.62% | 402,805 -2,665 | -0.7% | -$79.9K |
|
|
10
Qualcomm
QCOM
$173B
| $11.3M | 2.45% | 204,110 +46,060 | +29% | +$2.55M |
|
11
Coca-Cola
KO
$297B
| $7.48M | 1.62% | 172,115 -500 | -0.3% | -$21.7K |
|
12
ConocoPhillips
COP
$124B
| $7.03M | 1.53% | 118,565 -810 | -0.7% | -$48K |
|
|
13
Wells Fargo
WFC
$263B
| $6.62M | 1.44% | 126,256 -20,125 | -14% | -$1.05M |
|
14
Phillips 66
PSX
$54B
| $6.19M | 1.34% | 64,555 -340 | -0.5% | -$32.6K |
|
|
15
Gilead Sciences
GILD
$140B
| $5.97M | 1.29% | 79,167 +30,330 | +62% | +$2.29M |
|
16
Home Depot
HD
$405B
| $5.83M | 1.26% | 32,702 -300 | -0.9% | -$53.5K |
|
17
Helmerich & Payne
HP
$2.08B
| $5.73M | 1.24% | 86,010 -115 | -0.1% | -$7.66K |
|
18
US Bancorp
USB
$76B
| $4.86M | 1.06% | 96,295 -1,090 | -1% | -$55K |
|
19
Schlumberger
SLB
$55B
| $4.86M | 1.05% | 74,969 +2,059 | +3% | +$133K |
|
|
20
United Therapeutics
UTHR
$13.8B
| $4.35M | 0.94% | +38,697 | New | +$4.35M |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $4.22M | 0.92% | 247,155 -3,390 | -1% | -$57.9K |
|
22
APA Corp
APA
$8.31B
| $4.08M | 0.89% | 106,130 +45,675 | +76% | +$1.76M |
|
|
BBBY
23
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.3M | 0.72% | 157,315 +2,685 | +2% | +$56.4K |
|
24
PepsiCo
PEP
$204B
| $2.99M | 0.65% | 27,417 -330 | -1% | -$36K |
|
25
Cisco
CSCO
$274B
| $2.82M | 0.61% | 65,625 -310 | -0.5% | -$13.3K |
|